Genetic testing in children with Brugada syndrome: results from a large prospective registry
Europace · 2023
DOI: 10.1093/europace/euad079 ↗Kurz gefasst
Kommentar in der Zeitschrift Europace, 2023. Verfasst von Luigi Pannone und 27 weiteren Autor:innen. Beteiligte Einrichtung: Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brus…. Hauptthemen laut MEDLINE: Brugada Syndrome. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innoviris BRIDGE, Interdisciplinary Research Projects of the Vrje Universiteit Brussel.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aims
A pathogenic/likely pathogenic (P/LP) variant in SCN5A is found in 20–25% of patients with Brugada syndrome (BrS). However, the diagnostic yield and prognosis of gene panel testing in paediatric BrS is unclear. The aim of this study is to define the diagnostic yield and outcomes of SCN5A gene testing with ACMG variant classification in paediatric BrS patients compared with adults. Methods and results All consecutive patients diagnosed with BrS, between 1992 and 2022, were prospectively enrolled in the UZ Brussel BrS registry. Inclusion criteria were: (i) BrS diagnosis; (ii) genetic analysis performed with a large gene panel; and (iii) classification of gene variants following ACMG guidelines. Paediatric patients were defined as ≤16 years of age. The primary endpoint was ventricular arrhythmias (VAs). A total of 500 BrS patients were included, with 63 paediatric patients and 437 adult patients. Among children with BrS, 29 patients (46%) had a P/LP variant (P+) in SCN5A and no variants were found in 34 (54%) patients (P−). After a mean follow-up of 125.9 months, 8 children (12.7%) experienced a VA, treated with implanted cardioverter defibrillator shock. At survival analysis, P− paediatric patients had higher VA-free survival during the follow-up, compared with P+ paediatric patients. P+ status was an independent predictor of VA. There was no difference in VA-free survival between paediatric and adult BrS patients for both P− and P+.
Conclusion
In a large BrS cohort, the diagnostic yield for P/LP variants in the paediatric population is 46%. P+ children with BrS have a worse arrhythmic prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Laarbeeklaan, 101 1090 B…
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Clinical Sciences, Research Group Reproduction and Genetics, Centre for Medical Genetics, Brussels, Belgium.
- Cardiac Surgery Department, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Brussels, Belgium.
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Clinical Sciences, Research Group Reproduction and Genetics, Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), Brussels,…
ORCID-Profile: Luigi Pannone, Antonio Bisignani, Randy Osei, Anaïs Gauthey, Antonio Sorgente, Pasquale Vergara, Cinzia Monaco, Domenico Giovanni Della Rocca, Alvise Del Monte, Joerelle Mojica, Maysam Al Housari, Vincenzo Miraglia, Sahar Mouram, Robbert Ramak, Ingrid Overeinder, Alexandre Almorad, Erwin Ströker, Gudrun Pappaert, Mark La Meir, Pedro Brugada, Sonia Van Dooren, Carlo de Asmundis
Förderung
- Innoviris BRIDGE
- Interdisciplinary Research Projects of the Vrje Universiteit Brussel
Zitieren
APA
Pannone, L., Bisignani, A., Osei, R., Gauthey, A., Sorgente, A., Vergara, P., Monaco, C., Della Rocca, D. G., Del Monte, A., Strazdas, A., Mojica, J., Al Housari, M., Miraglia, V., Mouram, S., Paparella, G., Ramak, R., Overeinder, I., Bala, G., Almorad, A., …, & de Asmundis, C. (2023). Genetic testing in children with Brugada syndrome: results from a large prospective registry. Europace. https://doi.org/10.1093/europace/euad079
Vancouver
Pannone L, Bisignani A, Osei R, Gauthey A, Sorgente A, Vergara P, et al. Genetic testing in children with Brugada syndrome: results from a large prospective registry. Europace. 2023. doi:10.1093/europace/euad079
BibTeX
@article{Pannone2023,
author = {Pannone, Luigi and Bisignani, Antonio and Osei, Randy and Gauthey, Anaïs and Sorgente, Antonio and Vergara, Pasquale and Monaco, Cinzia and Della Rocca, Domenico Giovanni and Del Monte, Alvise and Strazdas, Antanas and Mojica, Joerelle and Al Housari, Maysam and Miraglia, Vincenzo and Mouram, Sahar and Paparella, Gaetano and Ramak, Robbert and Overeinder, Ingrid and Bala, Gezim and Almorad, Alexandre and Ströker, Erwin and Pappaert, Gudrun and Sieira, Juan and de Ravel, Thomy and La Meir, Mark and Brugada, Pedro and Chierchia, Gian Battista and Van Dooren, Sonia and de Asmundis, Carlo},
title = {Genetic testing in children with Brugada syndrome: results from a large prospective registry},
journal = {Europace},
year = {2023},
doi = {10.1093/europace/euad079}
}
EUVIMED